# Training in Translational Research of Skin Diseases

> **NIH NIH T32** · UNIVERSITY OF COLORADO DENVER · 2024 · $229,498

## Abstract

This is a resubmission of a renewal application for a highly successful training grant funded for 35 years
from the Department of Dermatology at the University of Colorado Anschutz Medical Campus (UCAMC). This
program began as an Immunodermatology training vehicle but has greatly changed in the past 13 years as the
research focus in this Department has broadened. The remarkable expansion of the research program in the
Department of Dermatology at UCAMC provided a perfect opportunity to restructure the scope and focus of
this training grant which initially occurred in the renewal application in 2014. To better reflect the breadth of our
training program, we have changed the title of our resubmission to the following: “Training in Translational
Research of Skin Diseases.” Dennis Roop and David Norris will continue to serve as Co-Directors and lead an
impressive multidisciplinary team of trainers and mentors, 15 of 26 of the current training faculty are new.
Several new developments in the Department of Dermatology and the Gates Center for Regenerative Medicine
have influenced the focus and organization of this renewal application, including the following: 1) the opening
of the Gates Biomanufacturing Facility (GBF), a state-of-the-art cGMP manufacturing facility translating
innovative research discoveries into safe and effective cell therapy and protein biologic products for human
clinical trials; 2) establishment of the EB iPS Cell Consortium, comprised of Colorado, Stanford and Columbia
universities, to fight the rare and debilitating genetic skin blistering disease Epidermolysis Bullosa (EB); and 3)
the establishment of a new Ehlers-Danlos Syndrome (EDS) Center of Excellence on the UCAMC.
 Historically, this has been a highly successful training grant, preparing clinical scientists for academic
careers, stimulating extensive research collaborations between scientists in Dermatology and other
departments, and supporting a highly productive research program in the Department of Dermatology. Of the
13 trainees who have been supported by this T32 during the last funding period (2015 to present), 10 are still
in training, 1 is completing a residency in Dermatology and 2 have taken positions in industry.
 This training grant will support 2 predoctoral and 4 postdoctoral training positions per year. Research
training in preceptor’s labs will be supplemented with a substantial program of enrichment including research
seminars, research in progress, lectures on relevant topics, and training in ethics. Unique training opportunities
for our T32 trainees include: 1) Training in the Manufacturing of Cells and Biologics for Clinical Use; 2)
Workshops on “Protection of Intellectual Property and Strategies for Commercialization”; and 3) Lectures on
“Introduction to Bioinformatic Tools for Analyzing Next Generation Sequencing Data”. Recruitment of
candidates for this program will be managed by a well-organized administrative structure and will include a
robust pl...

## Key facts

- **NIH application ID:** 10886746
- **Project number:** 5T32AR007411-39
- **Recipient organization:** UNIVERSITY OF COLORADO DENVER
- **Principal Investigator:** MARYAM Mandana ASGARI
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $229,498
- **Award type:** 5
- **Project period:** 1981-07-01 → 2026-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10886746

## Citation

> US National Institutes of Health, RePORTER application 10886746, Training in Translational Research of Skin Diseases (5T32AR007411-39). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10886746. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
